CFA Pharma
ActiveSummary
CFA Pharma has been active since 1986 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €153,937 and a net result of €6,743. Equity is growing by about 2.8% per year across the filed financial years. Its solvency ranks better than 46% of 22,595 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Directors
Directors
2 directors, last change in 2024
Board 2
BONTE Anne-Sophie
CurrentDirector · since 08-01-2024
MILDRO
CurrentDirector · since 08-01-2024 · Public limited company · permanent representative: VERBEKE Alexandre
Permanent representatives 1
VERBEKE Alexandre
CurrentPermanent representative · since 08-01-2024 · for MILDRO
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
3 of this company's 5 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
6 people since 2024, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| BONTE Anne-Sophie |
|
| MILDRO |
|
| Sampers Cécile |
|
| Sampers Gilbert |
|
| Sampers Hubert |
|
| Sampers Roza |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.